• Sonoma Pharmaceuticals held its annual shareholder meeting on Sept. 16, 2026.
• Shareholders backed the appointment of Frazier & Deeter as independent registered public accounting firm for the fiscal year ending March 31, 2027.
• Investors also authorized an adjournment to allow additional proxy solicitation if needed to secure sufficient votes on meeting items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007199), on September 17, 2026, and is solely responsible for the information contained therein.